¼¼°èÀÇ ³úô¼ö¾× ¹è¾× Ä«Å×ÅÍ ½ÃÀå
Cerebrospinal Fluid Drainage Catheters
»óǰÄÚµå : 1737553
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 272 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,136,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,408,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

³úô¼ö¾× ¹è¾× Ä«Å×ÅÍ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 4¾ï 2,500¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 3¾ï 3,910¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ³úô¼ö¾× ¹è¾× Ä«Å×ÅÍ ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 4¾ï 2,500¸¸ ´Þ·¯¿¡ ´ÞÇϰí, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 3.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¿äÃß ¹è¾× Ä«Å×ÅÍ´Â CAGR 3.2%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2¾ï 8,710¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³ú½Ç¿Ü¹è¾× Ä«Å×ÅÍ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 5.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 9,240¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ³úô¼ö¾× ¹è¾× Ä«Å×ÅÍ ½ÃÀåÀº 2024³â¿¡ 9,240¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 8,530¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 7.0%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.6%¿Í 2.9%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ³úô¼ö¾× ¹è¾× Ä«Å×ÅÍ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

³úô¼ö¾× ¹è¾× Ä«Å×ÅͰ¡ µÎ°³³»¾Ð ¹× ½Å°æÇÐÀû ÇÕº´Áõ °ü¸®¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

³úô¼ö¾×(CSF) ¹è¾× Ä«Å×ÅÍ´Â µÎ°³³»¾Ð(ICP) »ó½Â, ¼öµÎÁõ, ÁöÁÖ¸·ÇÏ ÃâÇ÷, ¿Ü»ó¼º ³ú¼Õ»ó(TBI), ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» °ü¸®Çϱâ À§ÇØ CSFÀÇ Á¦¾îµÈ ºÐ·ù¸¦ °¡´ÉÇϰÔÇÔÀ¸·Î½á ½Å°æ¿Ü°ú ¹× ÁßȯÀڽǿ¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ Ä«Å×ÅÍ´Â ÀϹÝÀûÀ¸·Î ¿äÃß ¶Ç´Â ³ú½ÇÀ» ÅëÇØ »ðÀԵǸç, Áø´Ü ¹× Ä¡·á ¸ñÀûÀ¸·Î »ç¿ëµÇ¸ç, ¾Ð·Â ¸ð´ÏÅ͸µ, °¨¿° ¿¹¹æ, ½Å°æÇÐÀû ¾ÇÈ­ À§Çè¿¡ óÇÑ È¯ÀÚÀÇ ¼ö¾× »ùÇøµÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù.

½Å°æ°è ÁßȯÀÚ Ä¡·áÀÇ Ç¥ÁØÈ­°¡ ÁøÇàµÊ¿¡ µû¶ó ³ú½Ç¿Ü ¹è¾×(EVD) ¹× ¿äÃß ¹è¾× ½Ã½ºÅÛÀÇ »ç¿ëÀº ³úÃâÇ÷ ¿¹¹æ, ºÎÁ¾ °¨¼Ò, ÁßÁõ ½Å°æ ¿Ü»ó ¹× ³ú¼ö¼ú ½Ã³ª¸®¿À¿¡¼­ ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇÑ ÇÁ·ÎÅäÄÝÀÇ ±âÃʰ¡ µÇ°í ÀÖ½À´Ï´Ù. ³úô¼ö¾× ´©Ãâ ¹× ³úô¼ö °¨¿° °ü¸®¿¡¼­ÀÇ À¯¿ë¼ºÀº º¹ÀâÇÑ ½Å°æÇÐÀû Ä¡·á¿¡¼­ ±× ¿ªÇÒÀ» ´õ¿í È®ÀåÇϰí ÀÖ½À´Ï´Ù.

CSF ¹è¾× Ä«Å×ÅÍÀÇ ¼º´ÉÀ» Çâ»ó½ÃŰ´Â ¼³°è Çõ½Å°ú °¨¿° °ü¸® Àü·«Àº ¹«¾ùÀΰ¡?

Á¦Ç° °³¹ßÀº Ä«Å×ÅÍÀÇ »ýüÀûÇÕ¼º, Á¤¹ÐÇÑ À¯·® Á¶Àý ¹× °¨¿° ÀúÇ×¼º Çâ»ó¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ÷´Ü Ä«Å×ÅÍ ½Ã½ºÅÛÀº ÇöÀç Ç×±Õ ÄÚÆÃ(Àº ÇÔħ ¶Ç´Â Ç×»ýÁ¦ ¿ëÃâ ¹°Áú µî), ¿À¿° À§ÇèÀ» ÁÙÀÌ´Â Æó¼â ¹ëºê ½Ã½ºÅÛ, ½Ç½Ã°£ ICP ¸ð´ÏÅ͸µÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â ÅëÇÕ ¾Ð·Â ¼¾¼­¸¦ Ư¡À¸·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº Ä«Å×ÅÍ °ü·Ã °¨¿°(¿¹ : ³ú½Ç¿°), Æó»ö, °úµµÇÑ ¹è¾×°ú °°Àº ÇÕº´Áõ¿¡ ´ëÀÀÇϱâ À§ÇÑ °ÍÀ¸·Î, ÀÌ·¯ÇÑ ÇÕº´ÁõÀº Áö±Ý±îÁö Àå±âÀûÀÎ ¾ÈÀü¼º°ú ÀÓ»óÀû äÅÃÀ» Á¦ÇÑÇØ ¿Ô½À´Ï´Ù.

ÀÚµ¿ ¹è¾× ½Ã½ºÅÛ°ú ÇÁ·Î±×·¡¹Ö °¡´ÉÇÑ ¹ëºê´Â ȯÀÚº° ICP ¸ñǥġ¿¡ ¸ÂÃç ÀϰüµÇ°í Á¶Àý °¡´ÉÇÑ ¼ö¾× À¯ÃâÀ» Á¦°øÇÏ´Â ´É·ÂÀ¸·Î ¸¹Àº »ç¶ûÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Åõ¸í Æ©ºê, º¯»ö ¹æÁö ¼ÒÀç, °­È­µÈ °íÁ¤ ¸ÞÄ¿´ÏÁòÀº ƯÈ÷ ¼Ò¾Æ, ¿Ü»ó ¹× Àå±â ÁßȯÀÚ½Ç È¯°æ¿¡¼­ ¼³Ä¡ ¾ÈÁ¤¼º°ú °ü¸® ¿ëÀ̼ºÀ» Çâ»ó½Ãŵ´Ï´Ù.

³úô¼ö¾× ¹è¾× Ä«Å×ÅÍÀÇ ¼ö¿ä´Â ¾îµð¿¡¼­ È®´ëµÇ°í ÀÖÀ¸¸ç, ¾î¶² ÀÓ»óÀû ¿ëµµ°¡ »ç¿ëÀ» ÃËÁøÇϰí Àִ°¡?

ºÏ¹Ì¿Í À¯·´Àº ¼º¼÷ÇÑ ½ÃÀåÀ¸·Î ½Å°æ¿Ü°ú ¼¾ÅÍ, ¿Ü»ó ÁßȯÀÚ½Ç, ´ëÇк´¿ø¿¡¼­ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ¿©ÀüÈ÷ ÁÖ¿ä äÅñ¹À̸ç, ÷´Ü ½Å°æ ÁßȯÀÚ Ä¡·á ÀÎÇÁ¶ó, ³ôÀº ½Ã¼ú·®, ICP °ü¸®¿¡ ´ëÇÑ ÀÓ»ó °¡À̵å¶óÀÎÀÇ ±¤¹üÀ§ÇÑ Áؼö¿¡ ÈûÀÔ¾î ¿©ÀüÈ÷ ÁÖ¿ä äÅñ¹ÀÔ´Ï´Ù. À¯·´Àº ±¸Á¶È­µÈ ¿Ü»ó ½Ã½ºÅÛ, ½Å°æÁ¾¾çÇÐ ¹× ³ú¼öµÎÁõ Ä¡·áÀÇ ¼ö¼ú °Ç¼ö Áõ°¡·Î ÀÎÇØ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ±× µÚ¸¦ ÀÕ°í ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº Àεµ, Áß±¹, µ¿³²¾Æ½Ã¾Æ¿¡¼­ ½Å°æÁßȯÀÚ Ä¡·á ÇÁ·ÎÅäÄÝ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ½Å°æ¿Ü°ú ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÊ¿¡ µû¶ó »õ·Î¿î °í¼ºÀå Áö¿ªÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ÀÀ¿ë ºÐ¾ß·Î´Â ¿Ü»ó¼º ³ú¼Õ»ó °ü¸®, µ¿¸Æ·ù¼º ÁöÁÖ¸·ÇÏ ÃâÇ÷ Ä¡·á, µÎ°³³» ÃâÇ÷ ¾ÈÁ¤È­, Á¾¾ç ÀýÁ¦¼ú ÈÄ °ü¸®, ¼±Ãµ¼º ¼öµÎÁõ¿¡ ´ëÇÑ °³ÀÔ µîÀÌ ÀÖ½À´Ï´Ù. ¼Ò¾Æ½Å°æ¼¾ÅÍ¿Í ½Å°æÁ¾¾ç¼¾ÅÍ¿¡¼­´Â ƯÈ÷ ¿äÃß Ä«Å×ÅÍ ½Ã½ºÅÛ°ú ÇÁ·Î±×·¡¹Ö °¡´ÉÇÑ Ä«Å×ÅÍ ½Ã½ºÅÛÀÇ »ç¿ë »ç·Ê°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

³úô¼ö¾× ¹è¾× Ä«Å×ÅÍ ½ÃÀåÀÇ ¼¼°è ¼ºÀå ¿øµ¿·ÂÀº?

³úô¼ö¾× ¹è¾× Ä«Å×ÅÍ ¼¼°è ½ÃÀåÀº ½Å°æÇÐÀû À§±â »óȲÀÇ ¹ß»ý·ü Áõ°¡, ÁßÃ߽Űæ°è °ü·Ã ¼ö¼úÀÇ Áõ°¡, Ç¥ÁØ Ä¡·á·Î¼­ µÎ°³³»¾Ð ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ Á߿伺 Áõ°¡·Î ÀÎÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ±â¼úÀû Áøº¸, °¨¿° °ü¸® ÇÁ·ÎÅäÄÝÀÇ °³¼±, ÁÁÀº ÀÓ»ó °á°úµéÀÌ ÀÓ»óÀǵéÀÇ ½Å·Úµµ¸¦ ³ô¿© ÀÇ·á ÇöÀå¿¡¼­ÀÇ »ç¿ëÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.

Ä«Å×ÅÍ ¼³°èÀÇ Áö¼ÓÀûÀÎ Çõ½ÅÀº ½Å°æ¿Ü°ú ¹× ÁßȯÀÚ Ä¡·áÀÇ ´ÙÇÐÁ¦Àû Ä¡·á ¸ðµ¨°ú °áÇÕÇÏ¿© º¸´Ù È¿À²ÀûÀÌ°í ¾ÈÀüÇÑ È¯ÀÚ ¸ÂÃãÇü ¼ö¾× °ü¸®¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ ½Å°æ°è ÀÎÇÁ¶ó ¹× ÃÖ¼Òħ½À ½Å°æ¿Ü°ú ±â¼ú¿¡ ÅõÀÚÇÏ´Â °¡¿îµ¥, ¾ÕÀ¸·ÎÀÇ ¼ºÀåÀ» Á¿ìÇÒ Áß¿äÇÑ Áú¹®ÀÌ ÀÖ½À´Ï´Ù. ³úô¼ö¾× ¹è¾× Ä«Å×ÅÍ ±â¼úÀÌ Ã·´Ü ÀÓ»ó ȯ°æ°ú ÀÚ¿øÀÌ Á¦ÇÑµÈ ÀÓ»ó ȯ°æ ¸ðµÎ¿¡¼­ ¿ì¼öÇÑ °¨¿° °ü¸®, Á¤È®¼º, Àå±âÀûÀÎ ½Å·Ú¼ºÀ» Á¦°øÇϸ鼭 È®Àå °¡´ÉÇÑ ½Å°æÄ¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖµµ·Ï ÁøÈ­ÇÒ ¼ö ÀÖÀ»±î?

ºÎ¹®

À¯Çü(¿äÃß ¹è¾× Ä«Å×ÅÍ, ³ú½Ç¿Ü¹è¾× Ä«Å×ÅÍ), ¿ëµµ(¿Ü»ó¼º ³ú¼Õ»ó, ¿Ü»ó¼º ôÃß ¼Õ»ó, ÁöÁÖ¸·ÇÏÃâÇ÷, ³ú³»ÃâÇ÷, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 32°³»ç)

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ÀÎÀ§ÀûÀÎ ¸ÅÃâ¿ø°¡ Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Global Industry Analysts´Â ¼¼°è ÁÖ¿ä ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®(1,4,949¸í), ½ÌÅ©ÅÊÅ©(62°³ ±â°ü), ¹«¿ª ¹× »ê¾÷ ´Üü(171°³ ±â°ü)ÀÇ Àü¹®°¡µéÀÇ ÀǰßÀ» ¸é¹ÐÈ÷ °ËÅäÇÏ¿© »ýŰ迡 ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ°í »õ·Î¿î ½ÃÀå Çö½Ç¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¸ðµç ÁÖ¿ä ±¹°¡ÀÇ Àü¹®°¡¿Í °æÁ¦ÇÐÀÚµéÀÌ °ü¼¼¿Í ±×°ÍÀÌ ÀÚ±¹¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀǰßÀ» ÃßÀû Á¶»çÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀÌ·¯ÇÑ È¥¶õÀÌ ÇâÈÄ 2-3°³¿ù ³»¿¡ ¸¶¹«¸®µÇ°í »õ·Î¿î ¼¼°è Áú¼­°¡ º¸´Ù ¸íÈ®ÇÏ°Ô È®¸³µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, Global Industry Analysts´Â ÀÌ·¯ÇÑ »óȲÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇϰí ÀÖ½À´Ï´Ù.

2025³â 4¿ù : Çù»ó ´Ü°è

À̹ø 4¿ù º¸°í¼­¿¡¼­´Â °ü¼¼°¡ ¼¼°è ½ÃÀå Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú Áö¿ªº° ½ÃÀå Á¶Á¤¿¡ ´ëÇØ ¼Ò°³ÇÕ´Ï´Ù. ´ç»çÀÇ ¿¹ÃøÀº °ú°Å µ¥ÀÌÅÍ¿Í ÁøÈ­ÇÏ´Â ½ÃÀå ¿µÇâ¿äÀÎÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.

2025³â 7¿ù : ÃÖÁ¾ °ü¼¼ Àç¼³Á¤

°í°´´Ôµé²²´Â °¢ ±¹°¡º° ÃÖÁ¾ ¸®¼ÂÀÌ ¹ßÇ¥µÈ ÈÄ 7¿ù¿¡ ¹«·á ¾÷µ¥ÀÌÆ® ¹öÀüÀ» Á¦°øÇØ µå¸³´Ï´Ù. ÃÖÁ¾ ¾÷µ¥ÀÌÆ® ¹öÀü¿¡´Â ¸íÈ®ÇÏ°Ô Á¤ÀÇµÈ °ü¼¼ ¿µÇ⠺м®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

»óÈ£ ¹× ¾çÀÚ °£ ¹«¿ª ¹× °ü¼¼ ¿µÇ⠺м®:

¹Ì±¹ <> Áß±¹ <> ¸ß½ÃÄÚ <> ij³ª´Ù <> EU <> ÀϺ» <> Àεµ <> ±âŸ 176°³±¹

¾÷°è ÃÖ°íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ® : Global Industry AnalystsÀÇ Áö½Ä ±â¹ÝÀº ±¹°¡, ½ÌÅ©ÅÊÅ©, ¹«¿ª ¹× »ê¾÷ ´Üü, ´ë±â¾÷, ±×¸®°í ¼¼°è °è·® °æÁ¦ »óȲÀÇ Àü·Ê ¾ø´Â ÆÐ·¯´ÙÀÓ ÀüȯÀÇ ¿µÇâÀ» °øÀ¯ÇÏ´Â ºÐ¾ßº° Àü¹®°¡ µî °¡Àå ¿µÇâ·Â ÀÖ´Â ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ Æ÷ÇÔÇÑ 14,949¸íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ ÃßÀûÇϰí ÀÖ½À´Ï´Ù. 16,491°³ ÀÌ»óÀÇ º¸°í¼­ ´ëºÎºÐ¿¡ ¸¶ÀϽºÅæ¿¡ ±â¹ÝÇÑ 2´Ü°è Ãâ½Ã ÀÏÁ¤ÀÌ Àû¿ëµÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cerebrospinal Fluid Drainage Catheters Market to Reach US$425.0 Million by 2030

The global market for Cerebrospinal Fluid Drainage Catheters estimated at US$339.1 Million in the year 2024, is expected to reach US$425.0 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Lumbar Drainage Catheter, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$287.1 Million by the end of the analysis period. Growth in the Ventricular Drainage Catheter segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$92.4 Million While China is Forecast to Grow at 7.0% CAGR

The Cerebrospinal Fluid Drainage Catheters market in the U.S. is estimated at US$92.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$85.3 Million by the year 2030 trailing a CAGR of 7.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Cerebrospinal Fluid Drainage Catheters Market - Key Trends & Drivers Summarized

Why Are Cerebrospinal Fluid Drainage Catheters Essential in Managing Intracranial Pressure and Neurological Complications?

Cerebrospinal fluid (CSF) drainage catheters play a critical role in neurosurgical and intensive care settings by enabling controlled diversion of CSF to manage elevated intracranial pressure (ICP), hydrocephalus, subarachnoid hemorrhage, traumatic brain injury (TBI), and post-operative complications. These catheters-commonly inserted via lumbar or ventricular access-serve both diagnostic and therapeutic purposes, facilitating pressure monitoring, infection prevention, and CSF sampling in patients at risk of neurological deterioration.

As neurocritical care becomes increasingly standardized, the use of external ventricular drains (EVDs) and lumbar drainage systems has become foundational in protocols aimed at preventing cerebral herniation, reducing edema, and improving patient outcomes in high-acuity neurotrauma and neurosurgery scenarios. Their utility in managing CSF leaks and cerebrospinal infections further expands their role in complex neurological care.

How Are Design Innovations and Infection Control Strategies Enhancing CSF Drainage Catheter Performance?

Product development is focused on improving catheter biocompatibility, precision flow regulation, and infection resistance. Advanced catheter systems now feature antimicrobial coatings (e.g., silver-impregnated or antibiotic-eluting materials), closed-valve systems to reduce contamination risk, and integrated pressure sensors to facilitate real-time ICP monitoring. These innovations are addressing complications such as catheter-associated infections (e.g., ventriculitis), occlusion, and over-drainage, which have historically limited long-term safety and clinical adoption.

Automated drainage systems and programmable valves are gaining traction for their ability to deliver consistent, adjustable CSF outflow tailored to patient-specific ICP targets. Additionally, transparent tubing, kink-resistant materials, and enhanced securing mechanisms are improving placement stability and ease of management, particularly in pediatric, trauma, and long-term ICU settings.

Where Is Demand for CSF Drainage Catheters Expanding and Which Clinical Applications Are Driving Utilization?

North America and Europe represent mature markets with high utilization in neurosurgery centers, trauma ICUs, and academic hospitals. The U.S. remains a key adopter, supported by advanced neurocritical care infrastructure, high procedure volumes, and widespread adherence to clinical guidelines for ICP management. Europe follows closely, with regional demand bolstered by structured trauma systems and rising surgical volumes in neuro-oncology and hydrocephalus treatment.

Asia-Pacific is an emerging high-growth region, with increased awareness of neurocritical care protocols and expanding access to neurosurgical services in India, China, and Southeast Asia. Key applications driving use include traumatic brain injury management, aneurysmal subarachnoid hemorrhage treatment, intracranial hemorrhage stabilization, tumor resection post-op care, and congenital hydrocephalus interventions. Pediatric neurology and neuro-oncology centers represent growing use cases, particularly for lumbar and programmable catheter systems.

What Is Fueling the Global Growth of the Cerebrospinal Fluid Drainage Catheters Market?

The global CSF drainage catheters market is expanding due to the increasing incidence of neurocritical conditions, rising surgical interventions involving the central nervous system, and the growing emphasis on intracranial pressure monitoring as a standard of care. Technological advancements, improved infection control protocols, and favorable clinical outcomes are enhancing clinician confidence and broadening use across care settings.

Ongoing innovation in catheter design, combined with multidisciplinary care models in neurosurgery and critical care, is supporting more efficient, safe, and patient-specific CSF management. As global healthcare systems invest in neurocritical infrastructure and minimally invasive neurosurgical techniques, a key question shapes future growth: Can cerebrospinal fluid drainage catheter technologies evolve to offer superior infection control, precision, and long-term reliability-while supporting scalable neurocare delivery across both advanced and resource-constrained clinical environments?

SCOPE OF STUDY:

The report analyzes the Cerebrospinal Fluid Drainage Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Lumbar Drainage Catheter, Ventricular Drainage Catheter); Application (Traumatic Brain Injury, Traumatic Spinal Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â